BioFire Defense LLC

Clinical trials sponsored by BioFire Defense LLC, explained in plain language.

Now part of bioMérieux S.A. BIM EURONEXT PARIS

Military-focused diagnostics subsidiary of bioMérieux, developing rapid pathogen detection.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.

Completed 1

New test aims to spot coronaviruses faster and more accurately

Diagnosis Completed

This study is testing a new diagnostic panel called the BioFire ECoV Panel, designed to detect coronaviruses from leftover nose swab samples. Researchers will enroll 1,500 people and compare the panel's results to standard tests to see how accurate it is. The test is not being us…

Sponsor: BioFire Defense LLC • Aim: Diagnosis

Last updated Aug 29, 2026 00:00 UTC

BioFire Defense LLC

New test aims to spot coronaviruses faster and more accurately